Literature DB >> 3792671

Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion.

N Havu.   

Abstract

Small intramucosal tumours in the oxyntic area of the rat stomach were observed in an oncogenicity study with omeprazole. The tumours could be defined as carcinoids of enterochromaffin-like (ECL) cell origin. ECL cells occur exclusively in oxyntic mucosa and respond to the trophic hormone gastrin with a proliferation that becomes exaggerated in old rats. Inhibition of gastric acid secretion is known to induce hypergastrinaemia in rats. According to the common concept of endocrine cells, a sustained hormonal stimulation with gastrin may induce a continuous gradient between hyperplasia and neoplasia of the ECL cells. The tumours found are thus to be regarded as hormone-induced endocrine tumours of the ECL cells in the stomach. The ECL-cell tumours of the rats in the oncogenicity study appeared to belong to the low-malignancy type of carcinoids and did not make their appearance until the end-life period of the study. The sex and species differences observed may be explained by inherent differences in gastrin response, spontaneous ECL cell density or in responsiveness to gastrin-stimulated ECL cell proliferation between sexes and species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792671     DOI: 10.1159/000199381

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  83 in total

1.  Indications for a neuroendocrine tumor-carcinoma sequence.

Authors:  H L Waldum; G Qvigstad; S Falkmer
Journal:  Virchows Arch       Date:  2001-08       Impact factor: 4.064

2.  Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine.

Authors:  Reidar Alexander Vigen; Mark Kidd; Irvin M Modlin; Duan Chen; Chun-Mei Zhao
Journal:  Med Mol Morphol       Date:  2012-06       Impact factor: 2.309

3.  Mechanism of acid hypersecretion post curative gastrinoma resection.

Authors:  Jeremiah V Ojeaburu; Tetsuhide Ito; Pellegrino Crafa; Cesare Bordi; Robert T Jensen
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

4.  Overutilization of proton-pump inhibitors: what the clinician needs to know.

Authors:  Joel J Heidelbaugh; Andrea H Kim; Robert Chang; Paul C Walker
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

5.  Hypergastrinaemia in patients infected with Helicobacter pylori treated with proton pump inhibitors.

Authors:  H L Waldum
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

6.  Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.

Authors:  Tan Attila; Raj Santharam; Dennis Blom; Richard Komorowski; Timothy R Koch
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

7.  Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.

Authors:  L A García Rodríguez; J Lagergren; M Lindblad
Journal:  Gut       Date:  2006-06-19       Impact factor: 23.059

Review 8.  Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; R T Jensen
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

Review 9.  Gastrin: old hormone, new functions.

Authors:  Graham Dockray; Rod Dimaline; Andrea Varro
Journal:  Pflugers Arch       Date:  2004-10-05       Impact factor: 3.657

Review 10.  Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach.

Authors:  Helge L Waldum; Øyvind Hauso; Øystein F Sørdal; Reidar Fossmark
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.